[{"type": "title", "data": "OB Induction of Labour with Mifepristone and Misoprostol (Multiphase)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "This order set is intended for medical termination of pregnancy and stillbirth - DO NOT USE for viable fetus", "value": ""}, {"type": "note", "data": "Nurse to initiate the Induction of Labour phase of this plan", "value": ""}, {"type": "category", "data": "Status"}, {"type": "order", "data": "Code Status", "value": "checked"}, {"type": "sentence", "data": "Attempt CPR, Full Code"}, {"type": "sentence", "data": "1-No CPR, Supportive Care, No Intubation"}, {"type": "sentence", "data": "2-No CPR, Therapeutic Care,No Intubation"}, {"type": "sentence", "data": "3-No CPR, Acute Transfer, No Intubation"}, {"type": "sentence", "data": "4-No CPR, Critical Care, No Intubation"}, {"type": "sentence", "data": "5-No CPR, Critical Care, May Intubate"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "q4h, then q1h when in active labour"}, {"type": "order", "data": "Weight", "value": "checked"}, {"type": "sentence", "data": "once"}, {"type": "order", "data": "Monitor Intake and Output", "value": ""}, {"type": "sentence", "data": "q12h, when in active labour"}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "When membranes rupture for 2 hours AND temperature is greater than or equal to 39 DegC OR if delivery has not occurred within 24 hours"}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "If temperature above 39 DegC"}, {"type": "order", "data": "Nitrous Oxide Gas Administration", "value": "checked"}, {"type": "sentence", "data": "PRN, For pain management"}, {"type": "category", "data": "Activity"}, {"type": "order", "data": "Activity as Tolerated", "value": "checked"}, {"type": "sentence", "data": "T;N"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "note", "data": "Review the most current diet order for therapeutic requirements, food texture and fluid thickness. Add anything to be carried forward to the new Diet Order", "value": ""}, {"type": "order", "data": "Maternity/Lactation Diet", "value": "checked"}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Diabetes Diet", "value": ""}, {"type": "sentence", "data": "Diabetes Maternity"}, {"type": "order", "data": "Adjust Diet As Tolerated", "value": "checked"}, {"type": "sentence", "data": "Start: Other (Please Specify), Advance to: Clear Fluid Diet, From Maternity/Lactation Diet, when in active labour"}, {"type": "order", "data": "NPO for Procedure", "value": "checked"}, {"type": "sentence", "data": "After delivery of the fetus until delivery of the placenta"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "Insert Peripheral IV (Intravenous) Catheter\u00a0", "value": ""}, {"type": "sentence", "data": "#18 gauge catheter"}, {"type": "order", "data": "dextrose 5%-sodium chloride 0.9% (D5NS) continuous infusion", "value": ""}, {"type": "sentence", "data": "order rate: 125 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 80 mL/h, IV, drug form: bag"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Do not select miFEPRIStone if it has been given as an outpatient", "value": ""}, {"type": "note", "data": "Consider consulting pharmacy before ordering miFEPRIstone if patient is on multiple medications and requires review for drug interactions", "value": ""}, {"type": "note", "data": "Considerations (Pre-Existing Medical Conditions):  \n- Renal or Hepatic failure: Do not administer miFEPRIStone if there is advanced renal or hepatic failure  \n- Asthma or COPD: Do not administer miFEPRIStone if severe and uncontrolled asthma or COPD  \n- Adrenal Failure: Do not administer miFEPRIStone because of the anti-glucocorticoid effect  \n- Cardiac (Long QT Syndrome): Do not administer miFEPRIstone as risk of arrhythmia. miFEPRIstone may prolong the QTc interval. miFEPRIstone is contraindicated in patients with a history of prolonged QTc  \n- Haemorrhagic Disorders: Consult hematology. miFEPRIstone may increase risk of bleeding  \n- Porphyria: Do not administer as miFEPRIstone can precipitate or exacerbate attacks of acute porphyria  \n- Diabetes:  Consult endocrine when admitted for induction. miFEPRIstone can affect glucose metabolism", "value": ""}, {"type": "note", "data": "Additional considerations (Medications):  \n- Assess if patient is on anticoagulants and consider consulting Hematology and Anesthesia  \n- Steroids (including inhaled steroids): consider consulting OB Internal Medicine if patient is taking steroids regarding indication and stress dose steroids at delivery  \n- miFEPRIstone may prolong the QTc interval. If patient is on, or is expected to receive, multiple QTc prolonging medications, consider doing an ECG. miFEPRIstone is contraindicated in patients with a history of prolonged QTc", "value": ""}, {"type": "order", "data": "miFEPRIStone", "value": ""}, {"type": "sentence", "data": "200 mg, PO, once, drug form: tab"}, {"type": "note", "data": "Right click and modify the following communication order to document date/time miFEPRIstone has been given as outpatient", "value": ""}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "miFEPRIstone has been given as an outpatient on date/time: ______"}, {"type": "order", "data": "Contraindication Order", "value": ""}, {"type": "sentence", "data": "miFEPRIstone is contraindicated or declined"}, {"type": "note", "data": "Re-evaluate miSOPROStol if undelivered after 24 hours", "value": ""}, {"type": "note", "data": "For no uterine scar less than 34 Weeks gestation", "value": ""}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "200 mcg, vaginal, q3h, order duration: 24 hour, drug form: tab"}, {"type": "note", "data": "For no uterine scar greater than or equal to 34 Weeks gestation", "value": ""}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "100 mcg, vaginal, q3h, order duration: 24 hour, drug form: tab"}, {"type": "note", "data": "For previous Caesarean section less than 24 Weeks gestation", "value": ""}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "200 mcg, vaginal, q3h, order duration: 24 hour, drug form: tab"}, {"type": "note", "data": "For previous Caesarean section greater than or equal to 24 Weeks gestation", "value": ""}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "50 mcg, vaginal, once, drug form: tab"}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "100 mcg, vaginal, q3h, order duration: 21 hour, drug form: tab"}, {"type": "note", "data": "Other doses or routes of administration", "value": ""}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "mcg, vaginal, drug form: tab"}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "mcg, PO, drug form: tab"}, {"type": "sentence", "data": "50 mcg, buccal, q3h, drug form: tab"}, {"type": "note", "data": "Post delivery of fetus", "value": ""}, {"type": "note", "data": "BCW provider to select oxytocin 50 unit/500 mL bag size", "value": ""}, {"type": "order", "data": "oxytocin continuous infusion (0.1 units/mL) in NS", "value": "checked"}, {"type": "sentence", "data": "10 unit, 83.33 milliunit/min"}, {"type": "sentence", "data": "order rate: 50 mL/h, IV"}, {"type": "order", "data": "oxytocin continuous infusion (0.1 units/mL) in NS", "value": ""}, {"type": "sentence", "data": "order rate: 50 mL/h, IV"}, {"type": "sentence", "data": "50 unit, 83.33 milliunit/min"}, {"type": "order", "data": "miSOPROStol", "value": "checked"}, {"type": "sentence", "data": "200 mcg, buccal, once, drug form: tab"}, {"type": "order", "data": "LORazepam PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 1 to 2 mg, sublingual, q6h, PRN anxiety, drug form: tab-sublingual"}, {"type": "order", "data": "acetaminophen PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 650 to 975 mg, PO, q4h, PRN pain-mild or fever, drug form: tab"}, {"type": "order", "data": "acetaminophen PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 650 to 975 mg, rectal, q4h, PRN pain-mild or fever, drug form: supp"}, {"type": "order", "data": "naproxen", "value": ""}, {"type": "sentence", "data": "500 mg, PO, q12h, PRN pain, drug form: tab"}, {"type": "note", "data": "Opioid Analgesics", "value": ""}, {"type": "note", "data": "If hydromorphone or morphine selected, select metoclopramide", "value": ""}, {"type": "order", "data": "HYDROmorphone PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 2 to 4 mg, PO, q3h, PRN pain-moderate, drug form: tab"}, {"type": "order", "data": "morphine PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 10 to 15 mg, IM, q3h, PRN pain, drug form: inj"}, {"type": "order", "data": "metoclopramide", "value": ""}, {"type": "sentence", "data": "10 mg, PO, q6h, PRN nausea or vomiting, drug form: tab"}, {"type": "order", "data": "metoclopramide", "value": ""}, {"type": "sentence", "data": "10 mg, IV, q6h, PRN nausea or vomiting, drug form: inj"}, {"type": "note", "data": "Refer to Fentanyl: Protocol for Labour", "value": ""}, {"type": "order", "data": "fentanyl", "value": ""}, {"type": "sentence", "data": "0.5 mcg/kg, IV, q5min, PRN pain-severe, order duration: 4 doses or times, drug form: inj"}, {"type": "order", "data": "Sedation Assessment", "value": "checked"}, {"type": "sentence", "data": "Follow Pasero Opioid-Induced sedation scale"}, {"type": "order", "data": "naloxone", "value": "checked"}, {"type": "sentence", "data": "0.1 mg, IV, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, q4h, PRN nausea or vomiting, drug form: tab"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "50 mg, IM, q4h, PRN nausea or vomiting, drug form: inj"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "50 mg, IV, q4h, PRN nausea or vomiting, drug form: inj"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Group and Screen", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "note", "data": "Consider consultation with Endocrinology, Hematology, Anesthesia and OB Internal Medicine", "value": ""}, {"type": "order", "data": "Notify Treating Provider", "value": ""}, {"type": "sentence", "data": "Notify anesthesia for consideration of epidural catheter insertion for moderate to severe pain"}, {"type": "order", "data": "Social Work Consult", "value": ""}, {"type": "sentence", "data": "Other (please specify), perinatal loss"}, {"type": "sentence", "data": "Family Care Conference or Meeting Needed"}, {"type": "sentence", "data": "Abuse or Neglect"}, {"type": "sentence", "data": "Substitute Decision Maker or Next of Kin"}, {"type": "sentence", "data": "End of Life, Code Blue, Death"}, {"type": "sentence", "data": "Discharge Planning or Coordinate of Care"}, {"type": "sentence", "data": "Mental Health or Substance Use"}, {"type": "sentence", "data": "Caregiver Stress"}, {"type": "sentence", "data": "Financial, Housing, Homelessness"}, {"type": "sentence", "data": "Life Altering Diagnosis"}, {"type": "sentence", "data": "Counselling"}, {"type": "sentence", "data": "Patient Identification"}, {"type": "sentence", "data": "Advance Care Planning"}, {"type": "order", "data": "Spiritual Health Services Consult", "value": ""}, {"type": "sentence", "data": "Spiritual Suffering(e.g. anxiety, grief)"}, {"type": "sentence", "data": "AHCP/End of Life/MAiD"}, {"type": "sentence", "data": "Beliefs Affecting Cooperation with Team"}, {"type": "sentence", "data": "Spiritual Values Clarification/Decisions"}, {"type": "sentence", "data": "Support for Family/Friends"}, {"type": "sentence", "data": "RC Priest/Clergy/Elder (please specify)"}, {"type": "sentence", "data": "Other (please specify)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Nurse to initiate Post Delivery phase of this PowerPlan", "value": ""}, {"type": "order", "data": "Nurse to Discontinue Order Set/Phase", "value": "checked"}, {"type": "sentence", "data": "Discontinue the Induction of Labour phase of the OB Induction of Labour with Mifepristone and Misoprostol PowerPlan"}, {"type": "category", "data": "Status"}, {"type": "order", "data": "Code Status", "value": "checked"}, {"type": "sentence", "data": "Attempt CPR, Full Code"}, {"type": "sentence", "data": "1-No CPR, Supportive Care, No Intubation"}, {"type": "sentence", "data": "2-No CPR, Therapeutic Care,No Intubation"}, {"type": "sentence", "data": "3-No CPR, Acute Transfer, No Intubation"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "q15min for 1 hour, then q1h until stable, then qshift"}, {"type": "sentence", "data": "q15min for 1 hour, then q1h until stable, then q4h"}, {"type": "sentence", "data": "q15min for 1 hour, then q1h until stable, then q6h"}, {"type": "order", "data": "Insert Urinary Catheter", "value": "checked"}, {"type": "sentence", "data": "PRN, If patient unable to void x 3, insert catheter"}, {"type": "order", "data": "Provide Sitz Bath", "value": ""}, {"type": "sentence", "data": "PRN"}, {"type": "order", "data": "Apply Ice Pack", "value": ""}, {"type": "sentence", "data": "PRN, to perineum x 24 hour"}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "Excessive bleeding, greater than 100 mL/h"}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "If placenta retained for more than 2 hours post-delivery"}, {"type": "note", "data": "If gestational diabetes", "value": ""}, {"type": "order", "data": "POC Glucose Whole Blood", "value": ""}, {"type": "sentence", "data": "once, before breakfast when tolerating diet. If not staying overnight, instruct patient to test at home before breakfast and call MD if greater than 6 mmol/L. If unable to test at home, have provider to arrange a GTT at 6 to 12 weeks post delivery"}, {"type": "sentence", "data": "once, before breakfast when tolerating diet"}, {"type": "sentence", "data": "qdaily, before breakfast when tolerating diet"}, {"type": "order", "data": "POC Glucose Whole Blood", "value": ""}, {"type": "sentence", "data": "once PRN, before breakfast. Repeat next morning before breakfast if greater than 6 mmol/L on the first day of testing. If repeat blood glucose greater than 6 mmol/L, call endocrinologist prior to discharge"}, {"type": "category", "data": "Activity"}, {"type": "order", "data": "Activity as Tolerated", "value": "checked"}, {"type": "sentence", "data": "T;N"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "note", "data": "Review the most current diet order for therapeutic requirements, food texture and fluid thickness. Add anything to be carried forward to the new Diet Order", "value": ""}, {"type": "order", "data": "Maternity/Lactation Diet", "value": "checked"}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Diabetes Diet", "value": ""}, {"type": "sentence", "data": "Diabetes Maternity, Calorie content of 2000 kCal"}, {"type": "sentence", "data": "Diabetes Maternity, Calorie content of 1800 kCal"}, {"type": "sentence", "data": "Diabetes Maternity, Calorie content of 2200 kCal"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "Saline Lock Peripheral IV", "value": "checked"}, {"type": "sentence", "data": "PRN"}, {"type": "order", "data": "Remove Peripheral IV Catheter", "value": "checked"}, {"type": "sentence", "data": "Continue IV access until bleeding stable and IV medication completed"}, {"type": "order", "data": "sodium chloride 0.9% (NS) continuous infusion", "value": ""}, {"type": "sentence", "data": "order rate: 125 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 100 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 80 mL/h, IV, drug form: bag"}, {"type": "order", "data": "dextrose 5%-sodium chloride 0.9% (D5NS) continuous infusion", "value": "checked"}, {"type": "sentence", "data": "order rate: 125 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 100 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 80 mL/h, IV, drug form: bag"}, {"type": "order", "data": "lactated ringers continuous infusion", "value": ""}, {"type": "sentence", "data": "order rate: 125 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 100 mL/h, IV, drug form: bag"}, {"type": "sentence", "data": "order rate: 80 mL/h, IV, drug form: bag"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Post delivery of fetus", "value": ""}, {"type": "note", "data": "BCW provider to select oxytocin 50 unit/500 mL bag size", "value": ""}, {"type": "order", "data": "oxytocin continuous infusion (0.1 units/mL) in NS", "value": ""}, {"type": "sentence", "data": "order rate: 50 mL/h, IV"}, {"type": "sentence", "data": "10 unit, 83.33 milliunit/min"}, {"type": "order", "data": "oxytocin continuous infusion (0.1 units/mL) in NS", "value": "checked"}, {"type": "sentence", "data": "order rate: 50 mL/h, IV"}, {"type": "sentence", "data": "50 unit, 83.33 milliunit/min"}, {"type": "note", "data": "Self Medication Program", "value": ""}, {"type": "order", "data": "acetaminophen", "value": ""}, {"type": "sentence", "data": "650 mg, PO, q4h, PRN pain, drug form: tab"}, {"type": "order", "data": "ibuprofen", "value": ""}, {"type": "sentence", "data": "400 mg, PO, q4h, PRN pain, drug form: tab"}, {"type": "order", "data": "docusate", "value": ""}, {"type": "sentence", "data": "200 mg, PO, qHS, PRN constipation, drug form: cap"}, {"type": "order", "data": "ANUSOL HC EQUIV 0.5% oint", "value": ""}, {"type": "sentence", "data": "1 application, topical, BID, PRN other (see comment), drug form: oint"}, {"type": "note", "data": "Select if not ordered for Self Medication", "value": ""}, {"type": "order", "data": "acetaminophen", "value": ""}, {"type": "sentence", "data": "650 mg, PO, q4h, PRN pain, drug form: tab"}, {"type": "sentence", "data": "975 mg, PO, q6h, PRN pain, drug form: tab"}, {"type": "order", "data": "docusate", "value": ""}, {"type": "sentence", "data": "200 mg, PO, qHS, PRN constipation, drug form: cap"}, {"type": "order", "data": "ANUSOL HC EQUIV 0.5% oint", "value": ""}, {"type": "sentence", "data": "1 application, topical, BID, PRN other (see comment), drug form: oint"}, {"type": "order", "data": "HYDROmorphone PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 1 to 4 mg, PO, q4h, PRN pain, drug form: tab"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, q4h, PRN nausea or vomiting, drug form: tab"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "50 mg, IV, q4h, PRN nausea or vomiting, drug form: inj"}, {"type": "order", "data": "metoclopramide", "value": ""}, {"type": "sentence", "data": "10 mg, PO, q6h, PRN nausea or vomiting, drug form: tab"}, {"type": "order", "data": "metoclopramide", "value": ""}, {"type": "sentence", "data": "10 mg, IV, q6h, PRN nausea or vomiting, drug form: inj"}, {"type": "order", "data": "naproxen", "value": ""}, {"type": "sentence", "data": "500 mg, PO, q12h, order duration: 24 hour, drug form: tab"}, {"type": "order", "data": "naproxen", "value": ""}, {"type": "sentence", "data": "500 mg, PO, q12h, PRN pain, order duration: 24 hour, drug form: tab"}, {"type": "order", "data": "diclofenac EC", "value": ""}, {"type": "sentence", "data": "50 mg, PO, q12h, order duration: 24 hour, drug form: tab-EC"}, {"type": "order", "data": "diclofenac EC", "value": ""}, {"type": "sentence", "data": "50 mg, PO, q12h, PRN pain, order duration: 24 hour, drug form: tab-EC"}, {"type": "order", "data": "diclofenac", "value": ""}, {"type": "sentence", "data": "50 mg, rectal, q12h, order duration: 24 hour, drug form: supp"}, {"type": "order", "data": "diclofenac", "value": ""}, {"type": "sentence", "data": "50 mg, rectal, q12h, PRN pain, order duration: 24 hour, drug form: supp"}, {"type": "order", "data": "ibuprofen", "value": ""}, {"type": "sentence", "data": "400 mg, PO, q4h, PRN pain, drug form: tab"}, {"type": "order", "data": "Sedation Assessment", "value": "checked"}, {"type": "sentence", "data": "Follow Pasero Opioid-Induced sedation scale"}, {"type": "order", "data": "naloxone", "value": "checked"}, {"type": "sentence", "data": "0.1 mg, IV, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "note", "data": "Consider suitability for measles, mumps and rubella vaccine", "value": ""}, {"type": "note", "data": "If rubella titre less than 10 units/mL", "value": ""}, {"type": "order", "data": "measles-mumps-rubella (MMR) vaccine", "value": ""}, {"type": "sentence", "data": "0.5 mL, subcutaneous, once, drug form: kit"}, {"type": "note", "data": "Varicella vaccine is to be given if the patient is VZV non immune", "value": ""}, {"type": "order", "data": "varicella vaccine", "value": ""}, {"type": "sentence", "data": "0.5 mL, subcutaneous, once, drug form: inj"}, {"type": "note", "data": "VTE Risk Assessment must be complete for all patients", "value": ""}, {"type": "sub phase", "data": "OB Postpartum VTE Thromboprophylaxis (Module)", "value": "checked"}, {"type": "sub phase", "data": "Diabetes in Pregnancy Postpartum (Module)", "value": ""}, {"type": "sub phase", "data": "OB Gestational Hypertension and Pre-Eclampsia Postpartum (Module)", "value": ""}, {"type": "sub phase", "data": "OB Acute Management of Severe Hypertension (Intrapartum / Postpartum) (Module)", "value": ""}, {"type": "sub phase", "data": "OB Magnesium Sulfate Administration for Fetal Neuroprotection (Module)", "value": ""}, {"type": "sub phase", "data": "OB HIV Positive Postpartum (Module)", "value": ""}, {"type": "sub phase", "data": "Bowel Protocol (Module)", "value": ""}, {"type": "sub phase", "data": "Nicotine Replacement Therapy (NRT) (Module)", "value": ""}, {"type": "note", "data": "If patient has Type 1 Diabetes and is not followed by Endocrinology / Internal Medicine", "value": ""}, {"type": "sub phase", "data": "Insulin Subcutaneous for Patients Eating or NPO (Sliding Scale) (Module)", "value": ""}, {"type": "category", "data": "Blood Products"}, {"type": "note", "data": "If patient is Rh negative and gestational age greater than or equal to 20 weeks, order Fetal Maternal Hemorrhage and TM Rh Immune Globulin (RhIG/WinRho) (Module). If gestational age less than 20 weeks, then order TM Rh Immune Globulin (RhIG/WinRho). No Fetal Maternal Hemorrhage required", "value": ""}, {"type": "order", "data": "Fetal Maternal Hemorrhage", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "sub phase", "data": "TM Rh Immune Globulin (RhIG / WinRho) (Module)", "value": ""}, {"type": "sub phase", "data": "TM Red Blood Cell (RBC) Transfusion (Module)", "value": ""}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": ""}, {"type": "sentence", "data": "Blood, AM Draw, Collection: T+1;0330, once"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Social Work Consult", "value": ""}, {"type": "sentence", "data": "Other (please specify), perinatal loss"}, {"type": "sentence", "data": "Family Care Conference or Meeting Needed"}, {"type": "sentence", "data": "Abuse or Neglect"}, {"type": "sentence", "data": "Substitute Decision Maker or Next of Kin"}, {"type": "sentence", "data": "End of Life, Code Blue, Death"}, {"type": "sentence", "data": "Discharge Planning or Coordinate of Care"}, {"type": "sentence", "data": "Mental Health or Substance Use"}, {"type": "sentence", "data": "Caregiver Stress"}, {"type": "sentence", "data": "Financial, Housing, Homelessness"}, {"type": "sentence", "data": "Life Altering Diagnosis"}, {"type": "sentence", "data": "Counselling"}, {"type": "sentence", "data": "Patient Identification"}, {"type": "sentence", "data": "Advance Care Planning"}, {"type": "order", "data": "Spiritual Health Services Consult", "value": ""}, {"type": "sentence", "data": "Spiritual Suffering(e.g. anxiety, grief)"}, {"type": "sentence", "data": "AHCP/End of Life/MAiD"}, {"type": "sentence", "data": "Beliefs Affecting Cooperation with Team"}, {"type": "sentence", "data": "Spiritual Values Clarification/Decisions"}, {"type": "sentence", "data": "Support for Family/Friends"}, {"type": "sentence", "data": "RC Priest/Clergy/Elder (please specify)"}, {"type": "sentence", "data": "Other (please specify)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Nurse to NOT DISCONTINUE this phase please", "value": ""}, {"type": "category", "data": "Medications"}, {"type": "sub phase", "data": "OB Intrauterine Fetal Death Investigation (Module)", "value": ""}]
